{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Transderm+Scop%C2%AE", "query": { "intervention": "Transderm Scop®" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 63, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Transderm+Scop%C2%AE&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T17:31:09.681Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01202188", "title": "A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "indacaterol and glycopyrronium (QVA149)", "type": "DRUG" }, { "name": "glycopyrronium (NVA237)", "type": "DRUG" }, { "name": "indacaterol (QAB149)", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 2144, "start_date": "2010-09", "completion_date": "2012-03", "has_results": true, "last_update_posted_date": "2013-09-09", "last_synced_at": "2026-09-04T17:31:09.681Z", "location_count": 14, "location_summary": "Fullerton, California • Riverside, California • St. Petersburg, Florida + 11 more", "locations": [ { "city": "Fullerton", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Troy", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01202188" }, { "nct_id": "NCT01634139", "title": "Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Tiotropium low dose QD", "type": "DRUG" }, { "name": "Tiotropium high dose QD", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 403, "start_date": "2012-07", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2016-07-12", "last_synced_at": "2026-09-04T17:31:09.681Z", "location_count": 6, "location_summary": "Columbia, Missouri • Cincinnati, Ohio • Oklahoma City, Oklahoma + 3 more", "locations": [ { "city": "Columbia", "state": "Missouri" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Charleston", "state": "South Carolina" }, { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01634139" }, { "nct_id": "NCT00565266", "title": "Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "tiotropium bromide", "type": "DRUG" }, { "name": "salmeterol xinafoate", "type": "DRUG" }, { "name": "beclomethasone dipropionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 210, "start_date": "2008-05", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-09-04T17:31:09.681Z", "location_count": 10, "location_summary": "San Diego, California • San Francisco, California • Denver, Colorado + 7 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00565266" }, { "nct_id": "NCT00877383", "title": "Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "Indacaterol 150 μg", "type": "DRUG" }, { "name": "Tiotropium 18 μg", "type": "DRUG" }, { "name": "Placebo to indacaterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1142, "start_date": "2009-04", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2011-08-25", "last_synced_at": "2026-09-04T17:31:09.681Z", "location_count": 116, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Jasper, Alabama + 102 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00877383" }, { "nct_id": "NCT02845752", "title": "The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Stiolto Respimat", "type": "DRUG" }, { "name": "Placebo Respimat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "45 Years to 90 Years" }, "enrollment_count": 14, "start_date": "2017-03-01", "completion_date": "2018-08-06", "has_results": true, "last_update_posted_date": "2020-08-06", "last_synced_at": "2026-09-04T17:31:09.681Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02845752" }, { "nct_id": "NCT01431274", "title": "Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "tiotropium + olodaterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "olodaterol", "type": "DRUG" }, { "name": "Respimat", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 2624, "start_date": "2011-09", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2015-07-16", "last_synced_at": "2026-09-04T17:31:09.681Z", "location_count": 35, "location_summary": "Jasper, Alabama • Mobile, Alabama • Boulder, Colorado + 31 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Stamford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01431274" }, { "nct_id": "NCT01533935", "title": "Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "tiotropium + Olodaterol", "type": "DRUG" }, { "name": "Tiotropium", "type": "DRUG" }, { "name": "Olodaterol", "type": "DRUG" }, { "name": "Respimat", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 291, "start_date": "2012-02", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2015-09-15", "last_synced_at": "2026-09-04T17:31:09.681Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Austell, Georgia • Baltimore, Maryland + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Austell", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01533935" }, { "nct_id": "NCT04272255", "title": "Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Motion Sickness" ], "interventions": [ { "name": "scopolamine HBr", "type": "DRUG" }, { "name": "Transdermal Scopolamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Repurposed Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "59 Years", "sex": "ALL", "summary": "18 Years to 59 Years" }, "enrollment_count": 300, "start_date": "2019-04-22", "completion_date": "2020-07", "has_results": false, "last_update_posted_date": "2020-02-17", "last_synced_at": "2026-09-04T17:31:09.681Z", "location_count": 1, "location_summary": "Dayton, Ohio", "locations": [ { "city": "Dayton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04272255" }, { "nct_id": "NCT02085161", "title": "To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "placebo to tiotropium + olodaterol", "type": "DRUG" }, { "name": "tiotropium +olodaterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 304, "start_date": "2014-03", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2017-01-06", "last_synced_at": "2026-09-04T17:31:09.681Z", "location_count": 3, "location_summary": "San Diego, California • Torrance, California • Hartford, Connecticut", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Hartford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02085161" }, { "nct_id": "NCT01525615", "title": "A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Respimat inhaler", "type": "DEVICE" }, { "name": "tiotropium+olodaterol (low dose)", "type": "DRUG" }, { "name": "tiotropium + olodaterol (high dose)", "type": "DRUG" }, { "name": "placebo to tiotropium+olodaterol", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 404, "start_date": "2012-02", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2016-08-29", "last_synced_at": "2026-09-04T17:31:09.681Z", "location_count": 15, "location_summary": "Torrance, California • Hartford, Connecticut • Springfield, Illinois + 12 more", "locations": [ { "city": "Torrance", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Springfield", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Livonia", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01525615" } ] }